Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2013; 19(1): 86-91
Published online Jan 7, 2013. doi: 10.3748/wjg.v19.i1.86
Published online Jan 7, 2013. doi: 10.3748/wjg.v19.i1.86
Table 1 Patients characteristics
| Number of patients | n = 30 |
| Number of dilatations | 47 |
| Gender: male/female | 22/8 |
| Age at EBD (mean ± SD), yr | 32.5 ± 10.5 |
| Disease duration (mean ± SD), yr | 12.8 ± 8.0 |
| Median follow-up | 26 mo (range, 2-172 mo) |
| Medical therapy at first dilatation (%) | |
| None | 0 |
| 5-aminosalicylic acid: | 86.7 |
| Steroids: | 13.3 |
| Azathioprine/6-mercaptoprine: | 20.0 |
| Infliximab | 13.3 |
| Elemental diet: | 33.3 |
| Total parental nutrition: | 16.7 |
- Citation: Endo K, Takahashi S, Shiga H, Kakuta Y, Kinouchi Y, Shimosegawa T. Short and long-term outcomes of endoscopic balloon dilatation for Crohn’s disease strictures. World J Gastroenterol 2013; 19(1): 86-91
- URL: https://www.wjgnet.com/1007-9327/full/v19/i1/86.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i1.86